Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Akebia Therapeutics, Inc. | akba-ex211_9.htm |
| EX-31.1 - EX-31.1 - Akebia Therapeutics, Inc. | akba-ex311_10.htm |
| EX-99.1 - EX-99.1 - Akebia Therapeutics, Inc. | akba-ex991_13.htm |
| EX-31.2 - EX-31.2 - Akebia Therapeutics, Inc. | akba-ex312_11.htm |
| EX-32.1 - EX-32.1 - Akebia Therapeutics, Inc. | akba-ex321_12.htm |
| EX-10.4 - EX-10.4 - Akebia Therapeutics, Inc. | akba-ex104_737.htm |
| EX-10.29 - EX-10.29 - Akebia Therapeutics, Inc. | akba-ex1029_738.htm |
| 10-K - 10-K - Akebia Therapeutics, Inc. | akba-10k_20151231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statement (Form S-3 No. 333-203206) of Akebia Therapeutics, Inc., |
|
|
(2) |
Registration Statement (Form S-8 No. 333-196748) pertaining to the Amended and Restated 2008 Equity Incentive Plan, the 2014 Incentive Plan, and the 2014 Employee Stock Purchase Plan of Akebia Therapeutics, Inc., and |
|
|
(3) |
Registration Statement (Form S-8 No. 333-209469) pertaining to the 2014 Incentive Plan and the 2014 Employee Stock Purchase Plan of Akebia Therapeutics, Inc.; |
of our report dated March 14, 2016, with respect to the consolidated financial statements of Akebia Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 14, 2016